Breaking News Instant updates and real-time market news.

ARWR

Arrowhead

$26.43

0.62 (2.40%)

04:55
06/18/19
06/18
04:55
06/18/19
04:55

Arrowhead management to meet with Piper Jaffray

Meeting to be held in San Francisco, CA on June 18 hosted by Piper Jaffray

  • 18

    Jun

ARWR Arrowhead
$26.43

0.62 (2.40%)

01/07/19
PIPR
01/07/19
NO CHANGE
PIPR
Piper Jaffray optimistic on Arrowhead as multiple studies commencing
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $25 price target on Arrowhead Pharmaceuticals after the company announced it dosed the first patient in Phase I ARO-ANG3 study and will commence Phase I dosing of ARO-APOC3 upon CTA approval. The analyst also sees at least two additional TRiM RNAi candidates entering the clinic in 2019, including ARO-ENaC and ARO-HIF2. Most important, Arrowhead will initiate a potentially registrational Phase II/III study for ARO-AAT in Q1 of 2019.
04/16/19
PIPR
04/16/19
NO CHANGE
Target $33
PIPR
Overweight
Arrowhead price target raised to $33 from $25 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Arrowhead Pharmaceuticals to $33 from $25 after the company received FDA clearance to start a Phase II/III trial of wholly-owned ARO-AAT in Alpha-1 antitrypsin deficiency. The analyst increased his value for ARO-AAT and reiterates an Overweight rating on Arrowhead shares.
05/13/19
RILY
05/13/19
NO CHANGE
Target $26
RILY
Buy
Arrowhead price target raised to $26 from $19 at B. Riley FBR
B. Riley FBR analyst Mayank Mamtani raised his price target for Arrowhead Pharmaceuticals to $26 from $19 citing increased visibility into the company's three "high-value" cardio targets. The analyst sees "significant optionality" in Arrowhead's pipeline and he keeps a Buy rating on the shares. The analyst added ARO-APOC3 and ARO-ANG3 to his model, albeit with low probability of success given still the early stage of development. He keeps a Buy rating on the shares.
05/28/19
RILY
05/28/19
NO CHANGE
Target $32
RILY
Buy
Arrowhead price target raised to $32 from $26 at B. Riley FBR
B. Riley FBR analyst Mayank Mamtani raised his price target for Arrowhead Pharmaceuticals to $32 from $26 saying he remains bullish on the company;s continued data generation. Mamtani reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

AAXN

Axon

$73.22

-0.12 (-0.16%)

, MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Axon, MarketAxess »

Axon to replace…

AAXN

Axon

$73.22

-0.12 (-0.16%)

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
MarketAxess to replace L3 Technologies in S&P 500 at open on 7/1 »

Harris (HRS) is acquiring…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

HRS

Harris

$197.28

-0.07 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.81

-0.0026 (-0.32%)

17:04
06/24/19
06/24
17:04
06/24/19
17:04
Hot Stocks
Vista Gold CFO Jack Engele to retire, Douglas Tobler to succeed »

Vista Gold is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:03
06/24/19
06/24
17:03
06/24/19
17:03
Periodicals
Apple to announce Seattle expansion on Monday, Seattle Times reports »

According to a story by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.00

0.07 (0.47%)

, CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Hot Stocks
HP Enterprise appoints Crowdstrike CEO George Kurtz to Board of Directors »

Hewlett Packard…

HPE

HP Enterprise

$15.00

0.07 (0.47%)

CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

NGM

NGM Biopharmaceuticals

$13.88

0.1 (0.73%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Initiation
NGM Biopharmaceuticals initiated  »

NGM Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$13.81

-0.27 (-1.92%)

17:00
06/24/19
06/24
17:00
06/24/19
17:00
Hot Stocks
Armistice Capital reports 6.2% passive stake in Vanda Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated  »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$27.47

-0.73 (-2.59%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Hot Stocks
Park Hotels & Resorts announces sale of three non-core assets for $166M »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$79.64

-1.74 (-2.14%)

16:56
06/24/19
06/24
16:56
06/24/19
16:56
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

16:48
06/24/19
06/24
16:48
06/24/19
16:48
Syndicate
Krystal Biotech files to sell $100M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:40
06/24/19
06/24
16:40
06/24/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Genfit »

Genfit SA (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
06/24/19
06/24
16:40
06/24/19
16:40
General news
Fed's Kaplan wants to take more of a wait-and-see approach to policy »

Fed's Kaplan wants…

CHWY

Chewy

$31.52

-0.64 (-1.99%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Hot Stocks
Lone Pine Capital reports 6.1% passive stake in Chewy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Syndicate
ArQule files to sell common stock, no amount given »

SVB Leerink and RBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$12.55

-0.43 (-3.31%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Calyxt enters commercial crushing agreement with Landus Cooperative »

Calyxt announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CNAT

Conatus

$0.94

0.0019 (0.20%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Conatus 

Conatus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Terns announces licensing, collaboration agreement with Genfit »

Terns Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHC

Encompass Health

$61.64

-0.305 (-0.49%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Encompass Health makes investment in Medalogix »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.33

-0.065 (-1.92%)

16:32
06/24/19
06/24
16:32
06/24/19
16:32
Hot Stocks
Chico's FAS board approves amendment to company bylaws over share acquisition »

Chico's FAS issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBNK

Territorial Bancorp

$27.87

-0.12 (-0.43%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Hot Stocks
Territorial Bancorp declares special mid-year cash dividend of 10c per share »

Payable on July 22 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Syndicate
Breaking Syndicate news story on ArQule »

ArQule files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$266.83

0.58 (0.22%)

16:30
06/24/19
06/24
16:30
06/24/19
16:30
Hot Stocks
Costco VP Roland Michael Vachris sells almost $1M in company shares »

Costco VP Roland Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 03

    Oct

16:30
06/24/19
06/24
16:30
06/24/19
16:30
Options
Preliminary option volume of 15.3M today »

Preliminary option volume…

EB

Eventbrite

$16.07

-0.23 (-1.41%)

16:28
06/24/19
06/24
16:28
06/24/19
16:28
Hot Stocks
Foxhaven Asset Management reports 5.8% passive stake in Eventbrite »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.